{
  "trial_id": "NCT04472468",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "confirmed active malignancy",
      "label": "met",
      "evidence": "Burkitt's lymphoma"
    },
    {
      "criterion": "presence of at least moderate (>10cm) pericardial effusion on CT or Echocardiography",
      "label": "met",
      "evidence": "3cm x 1cm mass on the lateral wall of the right atrium"
    }
  ],
  "exclusion": [
    {
      "criterion": "previous history of open-heart surgery",
      "label": "unknown"
    },
    {
      "criterion": "previous history of pericardial window or pericardial instillation of sclerosing therapy",
      "label": "unknown"
    },
    {
      "criterion": "scheduled thoracic or cardiac surgery within the next 3 months",
      "label": "unknown"
    },
    {
      "criterion": "contraindications for endovascular procedure such as disseminated intravascular coagulopathy or significant ongoing bleeding tendency, and systemic septicaemia",
      "label": "unknown"
    }
  ],
  "notes": "Patient has Burkitt's lymphoma with a large pericardial effusion. No contraindications noted.",
  "_meta": {
    "topic_id": "4",
    "trial_id": "NCT04472468",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}